Scalpels, beams, drugs, and dreams: Challenges of stage IIIA-N2 non-small-cell lung cancer

被引：15

作者：

Johnson, David H.

Rusch, Valerie W.

Turrisi, Andrew T.

机构：

[1] Vanderbilt Univ, Sch Med, Div Hematol & Med Oncol, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Thorac Surg, New York, NY USA

[3] Wayne State Univ, Karmanos Canc Ctr, Dept Radiat Oncol, Detroit, MI USA

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2007年 / 99卷 / 06期

关键词：

D O I：

10.1093/jnci/djk107

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：415 / 418

页数：4

共 27 条

[1]

Albain KS, 2005, J CLIN ONCOL, V23, p624S

[2] The influence of hospital volume on survival after resection for lung cancer [J].

Bach, PB ;

Cramer, LD ;

Schrag, D ;

Downey, RJ ;

Gelfand, SE ;

Begg, CB .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) :181-188

[3] Phase III study of the eastern cooperative oncology group (ECOG 2597): Induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer [J].

Belani, CP ;

Wang, W ;

Johnson, DH ;

Wagner, H ;

Schiller, J ;

Veeder, M ;

Mehta, M .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :3760-3767

[4] From CHART to CHARTWEL in non-small cell lung cancer: Clinical radiobiological modelling of the expected change in outcome [J].

Bentzen, SM ;

Saunders, MI ;

Dische, S .

CLINICAL ONCOLOGY, 2002, 14 (05) :372-381

[5] Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984) [J].

Biesma, B. ;

Manegold, C. ;

Smit, H. J. M. ;

Willems, L. ;

Legrand, C. ;

Passioukov, A. ;

van Meerbeeck, J. P. ;

Giaccone, G. .

EUROPEAN JOURNAL OF CANCER, 2006, 42 (10) :1399-1406

[6] Oncogenic pathway signatures in human cancers as a guide to targeted therapies [J].

Bild, AH ;

Yao, G ;

Chang, JT ;

Wang, QL ;

Potti, A ;

Chasse, D ;

Joshi, MB ;

Harpole, D ;

Lancaster, JM ;

Berchuck, A ;

Olson, JA ;

Marks, JR ;

Dressman, HK ;

West, M ;

Nevins, JR .

NATURE, 2006, 439 (7074) :353-357

[7] A RANDOMIZED TRIAL OF INDUCTION CHEMOTHERAPY PLUS HIGH-DOSE RADIATION VERSUS RADIATION ALONE IN STAGE-III NON-SMALL-CELL LUNG-CANCER [J].

DILLMAN, RO ;

SEAGREN, SL ;

PROPERT, KJ ;

GUERRA, J ;

EATON, WL ;

PERRY, MC ;

CAREY, RW ;

FREI, EF ;

GREEN, MR .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (14) :940-945

[8] Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]):: a randomised controlled trial [J].

Douillard, Jean-Yves ;

Rosell, Rafael ;

De Lena, Mario ;

Carpagnano, Francesco ;

Ramlau, Rodryg ;

Gonzales-Larriba, Jose Luis ;

Grodzki, Tornasz ;

Pereira, Jose Rodrigues ;

Le Groumellec, Alain ;

Lorusso, Vito ;

Clary, Claude ;

Torres, Antonio J. ;

Dahabreh, Jabrail ;

Souquet, Pierre-Jean ;

Astudillo, Julio ;

Fournel, Pierre ;

Artal-Cortes, Angel ;

Jassem, Jacek ;

Koubkova, Leona ;

His, Patricia ;

Riggi, Marcella ;

Hurteloup, Patrick .

LANCET ONCOLOGY, 2006, 7 (09) :719-727

[9] Induction treatment before surgery for non-small cell lung cancer [J].

Eberhardt, WE ;

Albain, KS ;

Pass, H ;

Putnam, JB ;

Gregor, A ;

Assamura, H ;

Mornex, F ;

Senan, S ;

Belderbos, J ;

Westeel, V ;

Thomas, M ;

Van Schil, P ;

Vansteenkiste, J ;

Manegold, C ;

Mirimanoff, RO ;

Stuschke, M ;

Pignon, J ;

Rocmans, P ;

Shepherds, FA .

LUNG CANCER, 2003, 42 :S9-S14

[10] Multimodality therapy for stage III non-small-cell lung cancer [J].

Farray, D ;

Mirkovic, N ;

Albain, KS .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (14) :3257-3269

← 1 2 3 →